The role of thiols and disulfides on protein stability

Current Protein and Peptide Science

Volumn 10, Issue 6, 2009, Pages 614-625

  Trivedi, Maulik V ^a,b   Laurence, Jennifer S ^a   Siahaan, Teruna J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DITHIODIPYRIDINE; CYSTEINE; EPTIFIBATIDE; GLUTATHIONE; OXYTOCIN; SUBTILISIN; SUPEROXIDE DISMUTASE; THIOL; THIOREDOXIN;

ARTICLE; CHEMICAL MODIFICATION; CONFORMATIONAL TRANSITION; COVALENT BOND; DISULFIDE BOND; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTON TRANSPORT; THERMODYNAMICS; THROMBOSIS; X RAY CRYSTALLOGRAPHY;

CYSTEINE; DISULFIDES; KINETICS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEINS; SULFHYDRYL COMPOUNDS;

EID: 73549100208     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920309789630534     Document Type: Article

References (84)

1. Bio Approved biotechnology drugs. Guide to Biotechnology, 2007, http://www.bio.org/speeches/pubs/er/.
2. Cyran, R. The market for bioengineered protein drugs. BCC Research Reports and Reviews, 2004, http://www.bccresearch.com.
3. Goolcharran, C.; Cleland, J.L.; Keck, R.; Jones, A.J.; Borchardt, R.T. Comparison of the rates of deamidation, diketopiperazine formation and oxidation in recombinant human vascular endothelial growth factor and model peptides. AAPS PharmSci., 2000, 2, E5.
4. Goolcharran, C.; Stauffer, L.L.; Cleland, J.L.; Borchardt, R.T. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides. J. Pharm. Sci., 2000, 89, 818-825.
5. Lai, M.C.; Hageman, M.J.; Schowen, R.L.; Borchardt, R.T.; Laird, B.B.; Topp, E.M. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone). J. Pharm. Sci., 1999, 88, 1081-1089.
6. Zhao, F.; Yang, J.; Schoneich, C. Effects of polyaminocarboxylate metal chelators on iron-thiolate induced oxidation of methionineand histidine-containing peptides. Pharm. Res., 1996, 13, 931-938.
7. Yao, Y.; Yin, D.; Jas, G.S.; Kuczera, K.; Williams, T.D.; Schoneich, C.; Squier, T.C. Oxidative modification of a carboxylterminal vicinal methionine in calmodulin by hydrogen peroxide inhibits calmodulin-dependent activation of the plasma membrane Ca-ATPase. Biochemistry, 1996, 35, 2767-2787.
8. Li, S.; Nguyen, T.H.; Schoneich, C.; Borchardt, R.T. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry, 1995, 34, 5762-5772.
9. Manning, M.C.; Patel, K.; Borchardt, R.T. Stability of protein pharmaceuticals. Pharm. Res., 1989, 6, 903-918.
10. Xie, M.; Shahrokh, Z.; Kadkhodayan, M.; Henzel, W.J.; Powell, M.F.; Borchardt, R.T.; Schowen, R.L. Asparagine deamidation in recombinant human lymphotoxin: hindrance by three-dimensional structures. J. Pharm. Sci., 2003, 92, 869-880.
11. Bogdanowich-Knipp, S.J.; Chakrabarti, S.; Williams, T.D.; Dillman, R.K.; Siahaan, T.J. Solution stability of linear vs. cyclic RGD peptides. J. Pept. Res., 1999, 53, 530-541.
12. Wakankar, A.A.; Borchardt, R.T. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. J. Pharm. Sci., 2006, 95, 2321-2336.
13. Gruber, C.W.; Cemazar, M.; Heras, B.; Martin, J.L.; Craik, D.J. Protein disulfide isomerase: the structure of oxidative folding. Trends. Biochem. Sci., 2006, 31, 455-464.
14. Kadokura, H.; Katzen, F.; Beckwith, J. Protein disulfide bond formation in prokaryotes. Annu. Rev. Biochem., 2003, 72, 111-135.
15. Frand, A.R.; Cuozzo, J.W.; Kaiser, C.A. Pathways for protein disulphide bond formation. Trends Cell Biol., 2000, 10, 203-210.
16. Sevier, C.S.; Kaiser, C.A. Conservation and diversity of the cellular disulfide bond formation pathways. Antioxid. Redox Signal, 2006, 8, 797-811.
17. Kulp, M.S.; Frickel, E.M.; Ellgaard, L.; Weissman, J.S. Domain architecture of protein-disulfide isomerase facilitates its dual role as an oxidase and an isomerase in Ero1p-mediated disulfide formation. J. Biol. Chem., 2006, 281, 876-884.
18. Fomenko, D.E.; Gladyshev, V.N. Genomics perspective on disulfide bond formation. Antioxid. Redox Signal., 2003, 5, 397-402.
19. Beeby, M.; O'connor, B.D.; Ryttersgaard, C.; Boutz, D.R.; Perry, L.J.; Yeates, T.O. The genomics of disulfide bonding and protein stabilization in thermophiles. PLoS Biol., 2005, 3, 1549-1558.
20. Weissman, J.S.; Kim, P.S. A kinetic explanation for the rearrangement pathway of BPTI folding. Nat. Struct. Biol., 1995, 2, 1123-1130.
21. Dadlez, M.; Kim, P.S. A third native one-disulphide intermediate in the folding of bovine pancreatic trypsin inhibitor. Nat. Struct. Biol., 1995, 2, 674-679.
22. Arolas, J.L.; Aviles, F.X.; Chang, J.Y.; Ventura, S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem. Sci., 2006, 31, 292-301.
23. Zhang, Y.H.; Yan, X.; Maier, C.S.; Schimerlik, M.I.; Deinzer, M.L. Conformational analysis of intermediates involved in the in vitro folding pathways of recombinant human macrophage colony stimulating factor beta by sulfhydryl group trapping and hydrogen/ deuterium pulsed labeling. Biochemistry, 2002, 41, 15495-15504.
24. Lu, B.-Y.; Beck, P.J.; Chang, J.-Y. Oxidative folding of murine prion mPrP(23-231). Eur. J. Biochem., 2001, 268, 3767-3773.
25. Wang, X.-Y.; Meng, F.-G.; Zhou, H.-M. The role of disulfide bonds in the conformational stability and catalytic activity of phytase. Biochem. Cell Biol., 2004, 82, 329-334.
26. Singh, R.R.; Appu Rao, A.G. Reductive unfolding and oxidative refolding of a Bowman-Birk inhibitor from horsegram seeds (Dolichos biflorus): evidence for 'hyperreactive' disulfide bonds and rate-limiting nature of disulfide isomerization in folding. Biochim. Biophys. Acta, 2002, 1597, 280-291.
27. Voss, R.H.; Ermler, U.; Essen, L.-O.; Wenzl, G.; Kim, Y.-M.; Flecker, P. Crystal structure of the bifunctional soybean Bowman-Birk inhibitor at 0.28-nm resolution. Structural peculiarities in a folded protein conformation. Eur. J. Biochem., 1996, 242, 122-131.
28. Takagi, H.; Takahashi, T.; Momose, H.; Inouye, M.; Maeda, Y.; Matsuzawa, H.; Ohta, T. Enhancement of the thermostability of subtilisin E by introduction of a disulfide bond engineered on the basis of structural comparison with a thermophilic serine protease. J. Biol. Chem., 1990, 265, 6874-6878.
29. Villafranca, J.E.; Howell, E.E.; Oatley, S.J.; Nguyen Huu, X.; Kraut, J. An engineered disulfide bond in dihydrofolate reductase. Biochem., 1987, 26, 2182-2189.
30. Wedemeyer, W.J.; Welker, E.; Narayan, M.; Scheraga, H.A. Disulfide bonds and protein folding. Biochemistry, 2000, 39, 7032-7032.
31. Pace, C.N.; Grimsley, G.R.; Thomson, J.A.; Barnett, B.J. Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. J. Biol. Chem., 1988, 263, 11820-11825.
32. Sugimoto, H.; Nakaura, M.; Kosuge, Y.; Imai, K.; Miyake, H.; Karita, S.; Tanaka, A. Thermodynamic effects of disulfide bond on thermal unfolding of the starch-binding domain of Aspergillus niger glucoamylase. Biosci. Biotechnol. Biochem., 2007, 71, 1535-1541.
33. Davoodi, J.; Wakarchuk, W.W.; Carey, P.R.; Surewicz, W.K. Mechanism of stabilization of Bacillus circulans xylanase upon the introduction of disulfide bonds. Biophys. Chem., 2007, 125, 453-461.
34. Matsumura, M.; Becktel, W.J.; Levitt, M.; Matthews, B.W. Stabilization of phage T4 lysozyme by engineered disulfide bonds. Proc. Natl. Acad. Sci. USA, 1989, 86, 6562-6566.
35. Asgeirsson, B.; Adalbjornsson, B.V.; Gylfason, G.A. Engineered disulfide bonds increase active-site local stability and reduce catalytic activity of a cold-adapted alkaline phosphatase. Biochim. Biophys. Acta, 2007, 1774, 679-687.
36. Berezowska, I.; Chung, N.N.; Lemieux, C.; Wilkes, B.C.; Schiller, P.W. Cyclic dermorphin tetrapeptide analogues obtained via ring-closing metathesis. Acta Biochim. Pol., 2006, 53, 73-76.
37. Thibault, G.; Tardif, P.; Lapalme, G. Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists. J. Pharmacol. Exp. Ther., 2001, 296, 690-696.
38. Rossi, M.L.; Zavalloni, D. Inhibitors of platelets glycoprotein IIb/IIIa (GP IIb/IIIa) receptor: rationale for their use in clinical cardiology. Mini Rev. Med. Chem., 2004, 4, 703-709.
39. Gimpl, G.; Burger, K.; Politowska, E.; Ciarkowski, J.; Fahrenholz, F. Oxytocin receptors and cholesterol: interaction and regulation. Exp. Physiol., 2000, 85 Spec No, 41S-49S.
40. Bogdanowich-Knipp, S.J.; Jois, D.S.; Siahaan, T.J. The effect of conformation on the solution stability of linear vs. cyclic RGD peptides. J. Pept. Res., 1999, 53, 523-529.
41. Bogdanowich-Knipp, S.J.; Jois, S.D.; Siahaan, T.J. Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product. J. Pept. Res., 1999, 54, 43-53.
42. Lewis, U.J.; Peterson, S.M.; Bonewald, L.F.; Seavey, B.K.; Vanderlaan, W.P. An interchain disulfide dimer of human growth hormone. J. Biol. Chem., 1977, 252, 3697-3702.
43. Trivedi, M.; Davis, R.A.; Shabaik, Y.; Roy, A.; Verkhivker, G.; Laurence, J.S.; Middaugh, C.R.; Siahaan, T.J. The role of covalent dimerization on physical and chemical stability of EC1 domain of human E-cadherin. J. Pharm. Sci., 2009, 98, 3562-3574.
44. Ellman, G.L. Tissue sulfhydryl groups. Arc. Biochem. Biophys., 1959, 82, 70-77.
45. Robyt, J.F.; Ackerman, R.J.; Chittenden, C.G. Reaction of protein disulfide groups with Ellman's reagent: a case study of the number of sulfhydryl and disulfide groups in Aspergillus oryzae -amylase, papain, and lysozyme. Arch. Biochem. Biophys., 1971, 147, 262-269.
46. Sedlak, J.; Lindsay, R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem., 1968, 25, 192-205.
47. Riener, C.K.; Kada, G.; Gruber, H.J. Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4′-dithiodipyridine. Anal. Bioanal. Chem., 2002, 373, 266-276.
48. Wright, S.K.; Viola, R.E. Evaluation of methods for the quantitation of cysteines in proteins. Anal. Biochem., 1998, 265, 8-14.
49. Kosower, N.S.; Kosower, E.M.; Newton, G.L.; Ranney, H.M. Bimane fluorescent labels: labeling of normal human red cells under physiological conditions. Proc. Natl. Acad. Sci. USA, 1979, 76, 3382-3386.
50. Kosower, N.S.; Newton, G.L.; Kosower, E.M.; Ranney, H.M. Bimane fluorescent labels: characterization of the bimane labeling of human hemoglobin. Biochim. Biophys. Acta, 1980, 622, 201-209.
51. Packard, B.; Edidin, M.; Komoriya, A. Site-directed labeling of a monoclonal antibody: targeting to a disulfide bond. Biochemistry, 1986, 25, 3548-3552.
52. Faulstich, H.; Tews, P.; Heintz, D. Determination and derivatization of protein thiols by n-octyldithionitrobenzoic acid. Anal. Biochem., 1993, 208, 357-362.
53. Chinn, P.C.; Pigiet, V.; Fahey, R.C. Determination of thiol proteins using monobromobimane labeling and high-performance liquid chromatographic analysis: application to Escherichia coli thioredoxin. Anal. Biochem., 1986, 159, 143-149.
54. Holmgren, A.; Soderberg, B.O.; Eklund, H.; Branden, C.I. Three-dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution. Proc. Natl. Acad. Sci. USA, 1975, 72, 2305-2309.
55. Forman-Kay, J.D.; Clore, G.M.; Wingfield, P.T.; Gronenborn, A.M. High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution. Biochemistry, 1991, 30, 2685-2698.
56. Jeng, M.F.; Campbell, A.P.; Begley, T.; Holmgren, A.; Case, D.A.; Wright, P.E.; Dyson, H.J. High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin. Structure, 1994, 2, 853-868.
57. 13C NMR resonances of cysteinyl residues. J. Biomol. NMR, 1991, 1, 49-64.
58. Sharma, D.; Rajarathnam, K. 13C NMR chemical shifts can predict disulfide bond formation. J. Biomol. NMR, 2000, 18, 165-171.
59. Wishart, D.S.; Sykes, B.D.; Richards, F.M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry, 1992, 31, 1647-1651.
60. Wishart, D.S.; Sykes, B.D.; Richards, F.M. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol., 1991, 222, 311-333.
61. 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J. Biomol. NMR, 1994, 4, 171-180.
62. Piotukh, K.; Kosslick, D.; Zimmermann, J.; Krause, E.; Freund, C. Reversible disulfide bond formation of intracellular proteins probed by NMR spectroscopy. Free Radic. Biol. Med., 2007, 43, 1263-1270.
63. He, H.T.; Gürsoy, R.N.; Kupczyk-Subotkowska, L.; Tian, J.; Williams, T.; Siahaan, T.J. Synthesis and chemical stability of a disulfide bond in a model cyclic pentapeptide: Cyclo(1,4)-Cys-Gly-Phe-Cys-Gly-OH. J. Pharm. Sci., 2006, 95, 2222-2234.
64. Florence, M.T. Degradation of protein disulphide bonds in dilute alkali. Biochem. J., 1980, 189, 507-520.
65. Tous, G.I.; Wei, Z.; Feng, J.; Bilbulian, S.; Bowen, S.; Smith, J.; Strouse, R.; Mcgeehan, P.; Casas-Finet, J.; Schenerman, M.A. Characterization of a novel modification to monoclonal antibodies: Thioether cross-link of heavy and light Chains. Anal. Chem., 2005, 77, 2675-2682.
66. Kim, P.S.; Kim, K.R.; Arvan, P. Disulfide-linked aggregation of thyroglobulin normally occurs during nascent protein folding. Am. J. Physiol., 1993, 265, C704-711.
67. Bucala, R.; Manabe, S.; Urban, R.C.; Cerami, A. Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: In vitro and in vivo studies. Exp. Eye Res., 1985, 41, 353-363.
68. Manabe, S.; Bucala, R.; Cerami, A. Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts. J. Clin. Invest., 1984, 74, 1803-1810.
69. Hook, D.W.A.; Harding, J.J. The effect of modification of alphacrystallin by prednisolone-21-hemisuccinate and fructose 6-phosphate on chaperone activity. Dev. Ophthalmol., 2002, 35, 150-160.
70. Kelly, S.T.; Zydney, A.L. Effects of intermolecular thiol-disulfide interchange reactions on BSA fouling during microfiltration. Biotechnol. Bioeng., 1994, 44, 972-982.
71. Ruegg, U.; Rudinger, J. Alkylation of Cysteine Thiols with 1,3-Propane Sultone. In Hirs, C.H.W.; Timasheff, S.N.; Eds.; Methods in Enzymology. Volume 47: Elsevier Inc, USA, 1977, p. 116-122.
72. Smith, D.J.; Miggio, E.T.; Kenyon, G.L. Simple alkanethiol groups for temporary blocking of sulfhydryl groups of enzymes. Biochem., 1975, 14, 766-771.
73. Koizumi, S.; Suzuki, T.; Takahashi, S.; Satake, K.; Takeuchi, T.; Umezawa, H.; Nagatsu, T. Sulfhydryl modification and activation of phenylalanine hydroxylase by dinitrophenyl alkyl disulfide. Biochem., 1987, 26, 6461-6465.
74. Schwendeman, S.P.; Lee, J.H.; Gupta, R.K.; Costantino, H.R.; Siber, G.R.; Langer, R. Inhibition of moisture-induced aggregation of tetanus toxoid by protecting thiol groups. Proc. Intern. Sympos. Control. Rel. Bio. Mater., 1994, 21ST, 54.
75. Hallewell, R.A.; Imlay, K.C.; Lee, P.; Fong, N.M.; Gallegos, C.; Getzoff, E.D.; Tainer, J.A.; Cabelli, D.E.; Tekamp-Olson, P.; Mullenbach, G.T.; Cousens, L.S. Thermostabilization of recombinant human and bovine CuZn superoxide dismutases by replacement of free cysteines. Biochem. Biophys. Res. Commun., 1991, 181, 474-480.
76. Marchand, P.; Volkmann, M.; Bond, J.S. Cysteine mutations in the MAM domain result in monomeric meprin and alter stability and activity of the proteinase. J. Biol. Chem., 1996, 271, 24236-24241.
77. Rosendahl, M.S.; Doherty, D.H.; Smith, D.J.; Bendale, A.M.; Cox, G.N. Site specific protein PEGylation: Application to cysteine analogs of recombinant human granulocyte colony-stimulating factor. Bioprocess Intern., 2005, 3, 52-62.
78. Rosendahl, M.S.; Doherty, D.H.; Smith, D.J.; Carlson, S.J.; Chlipala, E.A.; Cox, G.N. A long acting, highly potent interferon α-2 conjugate created using site-specific PEGylation. Bioconjug. Chem., 2005, 16, 200-207.
79. Tsutsumi, Y.; Onda, M.; Nagata, S.; Lee, B.; Kreitman, R.J.; Pastan, I. Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity. Proc. Natl. Acad. Sci. USA, 2000, 97, 8548-8553.
80. Long, D.L.; Doherty, D.H.; Eisenberg, S.P.; Smith, D.J.; Rosendahl, M.S.; Christensen, K.R.; Edwards, D.P.; Chlipala, E.A.; Cox, G.N. Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity. Exp. Hematol., 2006, 34, 697-704.
81. Brocchini, S.; Balan, S.; Godwin, A.; Choi, J.W.; Zloh, M.; Shaunak, S. PEGylation of native disulfide bonds in proteins. Nat. Protoc. , 2006, 1, 2241-2252.
82. Balan, S.; Choi, J.W.; Godwin, A.; Teo, I.; Laborde, C.M.; Heidelberger, S.; Zloh, M.; Shaunak, S.; Brocchini, S. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. Bioconjug. Chem., 2007, 18, 61-76.
83. Basu, A.; Yang, K.; Wang, M.; Liu, S.; Chintala, R.; Palm, T.; Zhao, H.; Peng, P.; Wu, D.; Zhang, Z.; Hua, J.; Hsieh, M.C.; Zhou, J.; Petti, G.; Li, X.; Janjua, A.; Mendez, M.; Liu, J.; Longley, C.; Zhang, Z.; Mehlig, M.; Borowski, V.; Viswanathan, M.; Filpula, D. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. Bioconjug. Chem., 2006, 17, 618-630.
84. Parveen, S.; Sahoo, S.K. Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs. Clin. Pharmacokinet., 2006, 45, 965-988.